|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
FINERENONE |
C03DA05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
VOXELOTOR |
B06AX03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004869 |
14-02-2022 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
TECOVIRIMAT |
J05AX24 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
ABROCITINIB |
D11AH08 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ARTESUNATE |
P01BE03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
ZANUBRUTINIB |
L01EL03 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/004978 |
22-11-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
RIPRETINIB |
L01EX19 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
DE
|
POM
|
25-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
IDECABTAGENE VICLEUCEL |
L01XX00 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004662 |
18-08-2021 |
VALID
|
|
ROXADUSTAT |
B03XA05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004871 |
18-08-2021 |
VALID
|
|
ODEVIXIBAT |
A05AX05 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004691 |
16-07-2021 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
SATRALIZUMAB |
L04AC19 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/004788 |
24-06-2021 |
VALID
|
|
IODINE IOFLUPANE (123I) |
V09AB03 |
DE
|
POM
|
|
EMEA/H/C/005135 |
17-06-2021 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
DUVELISIB |
L01EM04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
PONESIMOD |
L04AE04 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
DE
|
POM
|
02-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
LATANOPROST AND NETARSUDIL |
S01EE51 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005107 |
07-01-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
DE
|
POM
|
08-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
LUMASIRAN |
A16AX18 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
FILGOTINIB |
L04AF04 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
REMDESIVIR |
J05AB16 |
DE
|
POM
|
18-01-2021 |
EMEA/H/C/005622 |
03-07-2020 |
VALID
|
|
ISATUXIMAB |
L01FC02 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004977 |
30-05-2020 |
VALID
|
|
CEFIDEROCOL |
J01DI04 |
DE
|
POM
|
22-12-2020 |
EMEA/H/C/004829 |
23-04-2020 |
VALID
|
|
DAROLUTAMIDE |
L02BB06 |
DE
|
POM
|
22-11-2023 |
EMEA/H/C/004790 |
27-03-2020 |
VALID
|
|
BROLUCIZUMAB |
S01LA06 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004913 |
13-02-2020 |
VALID
|
|
IMIPENEM, CILASTATIN AND RELEBACTAM |
J01DH56 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004808 |
13-02-2020 |
VALID
|
|
POLATUZUMAB VEDOTIN |
L01FX14 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004870 |
16-01-2020 |
VALID
|
|
SOLRIAMFETOL |
N06BA14 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004893 |
16-01-2020 |
VALID
|
|
OSILODROSTAT |
H02CA02 |
DE
|
POM
|
22-04-2020 |
EMEA/H/C/004821 |
09-01-2020 |
VALID
|
